• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞移植期间的维生素需求:系统评价。

Vitamin requirements during stem cell transplantation: a systematic review.

机构信息

The University of Queensland, Brisbane, QLD, Australia.

The Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

出版信息

Support Care Cancer. 2022 Dec;30(12):10391-10405. doi: 10.1007/s00520-022-07409-4. Epub 2022 Nov 9.

DOI:10.1007/s00520-022-07409-4
PMID:36347993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9715522/
Abstract

Patients undergoing stem cell transplantation (SCT) are at high risk of malnutrition during the acute post-transplantation period. This systematic review aimed to collate and analyse the evidence for vitamin requirements post-SCT. A systematic search of five databases was conducted to include studies published until March 2021. The review utilised the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) framework. Inclusion criteria consisted of adults undergoing SCT who received vitamin supplementation or had their vitamin levels monitored up to 100 days post-SCT. Studies with paediatric patients or those that looked at vitamin derivates such as folinic acid were excluded. Main outcomes included vitamin deficiency and relevant clinical outcomes. Eleven studies (n = 11) were eligible for inclusion with five rated as neutral quality and six as positive quality. Five studies focused on allogenic SCT, two on autologous SCT and the remaining included a mix of both. Eight studies monitored vitamins levels post-SCT, and seven studies provided vitamin supplementation. Three studies (one provided supplementation) found a high prevalence of vitamin D deficiency (23-60%) prior to SCT. Findings indicate an unclear association between vitamin deficiency and post-SCT complications including acute graft-versus-host-disease, oral mucositis, and mortality. The GRADE certainty of evidence across these outcomes was low or very low. It is unclear if supplementation is needed during SCT, though assessing vitamin D levels prior to transplant should be considered. Further large observational studies or randomised control trials are required to establish vitamin requirements and guide supplementation protocols during SCT.

摘要

接受干细胞移植 (SCT) 的患者在移植后急性期存在营养风险。本系统评价旨在整理和分析 SCT 后维生素需求的证据。对五个数据库进行了系统搜索,以纳入截至 2021 年 3 月发表的研究。本综述采用系统评价和荟萃分析的首选报告项目 (PRISMA) 框架。纳入标准包括接受维生素补充或监测维生素水平至 SCT 后 100 天的成人 SCT 患者。排除儿科患者或研究维生素衍生物(如叶酸)的研究。主要结局包括维生素缺乏和相关临床结局。有 11 项研究(n=11)符合纳入标准,其中 5 项研究质量为中性,6 项研究质量为阳性。五项研究专注于同种异体 SCT,两项研究专注于自体 SCT,其余研究包括两者的混合。八项研究监测 SCT 后维生素水平,七项研究提供维生素补充。三项研究(一项提供补充)发现 SCT 前维生素 D 缺乏症的患病率较高(23-60%)。结果表明,维生素缺乏与 SCT 后并发症(包括急性移植物抗宿主病、口腔黏膜炎和死亡率)之间的关联尚不清楚。这些结局的 GRADE 证据确定性为低或极低。目前尚不清楚 SCT 期间是否需要补充维生素,但应考虑在移植前评估维生素 D 水平。需要进一步进行大型观察性研究或随机对照试验,以确定 SCT 期间的维生素需求并指导补充方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6d1/9715522/d46817373766/520_2022_7409_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6d1/9715522/d46817373766/520_2022_7409_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6d1/9715522/d46817373766/520_2022_7409_Fig1_HTML.jpg

相似文献

1
Vitamin requirements during stem cell transplantation: a systematic review.干细胞移植期间的维生素需求:系统评价。
Support Care Cancer. 2022 Dec;30(12):10391-10405. doi: 10.1007/s00520-022-07409-4. Epub 2022 Nov 9.
2
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
5
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.嵌合抗原受体 (CAR) T 细胞疗法治疗复发或难治性弥漫性大 B 细胞淋巴瘤患者。
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2.
6
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Physical activity for treatment of irritable bowel syndrome.体力活动治疗肠易激综合征。
Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2.
9
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

引用本文的文献

1
Modern-Era Challenges in the Clinical Management of Graft-Versus-Host Disease.移植物抗宿主病临床管理中的现代挑战
Adv Exp Med Biol. 2025;1475:103-128. doi: 10.1007/978-3-031-84988-6_6.
2
Folate and Vitamin B12 Status in Pediatric Hematopoietic Stem Cell Transplantation Patients.儿科造血干细胞移植患者的叶酸和维生素B12状态
Nutrients. 2025 Jan 21;17(3):377. doi: 10.3390/nu17030377.
3
The Critical Exploration into Current Evidence behind the Role of the Nutritional Support in Adult Patients Who Undergo Haematogenic Stem Cell Transplantation.

本文引用的文献

1
ESPEN practical guideline: Clinical Nutrition in cancer.ESPEN 实践指南:癌症患者的临床营养。
Clin Nutr. 2021 May;40(5):2898-2913. doi: 10.1016/j.clnu.2021.02.005. Epub 2021 Mar 15.
2
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
3
Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation.维生素 E 与骨髓清除性异基因造血细胞移植后急性移植物抗宿主病。
成人血液系统干细胞移植患者营养支持作用的当前证据的批判性探索。
Nutrients. 2023 Aug 11;15(16):3558. doi: 10.3390/nu15163558.
Eur J Haematol. 2021 Mar;106(3):417-424. doi: 10.1111/ejh.13567. Epub 2020 Dec 19.
4
Effect of vitamin A on intestinal mucosal injury in pediatric patients receiving hematopoietic stem cell transplantation and chemotherapy: a quasai-randomized trial.维生素A对接受造血干细胞移植和化疗的儿科患者肠道黏膜损伤的影响:一项半随机试验。
BMC Res Notes. 2020 Oct 2;13(1):464. doi: 10.1186/s13104-020-05307-8.
5
Biomarkers in critical care nutrition.危重病营养中的生物标志物。
Crit Care. 2020 Aug 12;24(1):499. doi: 10.1186/s13054-020-03208-7.
6
Patients Undergoing Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation Exhibit Depleted Vitamin C Status in Association with Febrile Neutropenia.行骨髓清除性化疗和造血干细胞移植的患者表现出与发热性中性粒细胞减少症相关的维生素 C 状态耗竭。
Nutrients. 2020 Jun 24;12(6):1879. doi: 10.3390/nu12061879.
7
Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels.骨髓瘤和淋巴瘤患者血清维生素 D 水平低时,自体干细胞移植后生存率降低。
Hematol Oncol. 2020 Oct;38(4):523-530. doi: 10.1002/hon.2774. Epub 2020 Jul 29.
8
Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Adults.巴西造血干细胞移植成人营养共识
Einstein (Sao Paulo). 2020 Feb 7;18:AE4530. doi: 10.31744/einstein_journal/2020AE4530. eCollection 2020.
9
Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial.口服骨化三醇在自体造血干细胞移植后的造血恢复和生存中的作用:一项随机临床试验。
Daru. 2019 Dec;27(2):709-720. doi: 10.1007/s40199-019-00306-y. Epub 2019 Nov 11.
10
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors.造血干细胞移植后死亡:随时间推移的变化、感染及相关因素。
Bone Marrow Transplant. 2020 Jan;55(1):126-136. doi: 10.1038/s41409-019-0624-z. Epub 2019 Aug 27.